CN107853528A - A kind of turmeric lecithin solid beverage - Google Patents
A kind of turmeric lecithin solid beverage Download PDFInfo
- Publication number
- CN107853528A CN107853528A CN201711226937.0A CN201711226937A CN107853528A CN 107853528 A CN107853528 A CN 107853528A CN 201711226937 A CN201711226937 A CN 201711226937A CN 107853528 A CN107853528 A CN 107853528A
- Authority
- CN
- China
- Prior art keywords
- turmeric
- lecithin
- solid beverage
- blood
- function
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000003392 Curcuma domestica Nutrition 0.000 title claims abstract description 48
- 235000003373 curcuma longa Nutrition 0.000 title claims abstract description 48
- 235000013976 turmeric Nutrition 0.000 title claims abstract description 48
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 title claims abstract description 28
- 239000000787 lecithin Substances 0.000 title claims abstract description 28
- 229940067606 lecithin Drugs 0.000 title claims abstract description 28
- 235000010445 lecithin Nutrition 0.000 title claims abstract description 28
- 235000013361 beverage Nutrition 0.000 title claims abstract description 21
- 239000007787 solid Substances 0.000 title claims abstract description 21
- 244000008991 Curcuma longa Species 0.000 title 1
- 244000163122 Curcuma domestica Species 0.000 claims abstract description 47
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims abstract description 20
- 229940083466 soybean lecithin Drugs 0.000 claims abstract description 20
- 238000002360 preparation method Methods 0.000 claims description 5
- 238000007873 sieving Methods 0.000 claims 1
- 210000004369 blood Anatomy 0.000 abstract description 18
- 239000008280 blood Substances 0.000 abstract description 18
- 230000036541 health Effects 0.000 abstract description 9
- 206010028980 Neoplasm Diseases 0.000 abstract description 7
- 230000036772 blood pressure Effects 0.000 abstract description 6
- 235000013305 food Nutrition 0.000 abstract description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 5
- 239000008103 glucose Substances 0.000 abstract description 5
- 230000002929 anti-fatigue Effects 0.000 abstract description 2
- 230000005764 inhibitory process Effects 0.000 abstract description 2
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 20
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical group C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 10
- 235000012754 curcumin Nutrition 0.000 description 10
- 229940109262 curcumin Drugs 0.000 description 10
- 239000004148 curcumin Substances 0.000 description 10
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 10
- 230000006870 function Effects 0.000 description 10
- 239000000047 product Substances 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 208000024827 Alzheimer disease Diseases 0.000 description 5
- 235000012000 cholesterol Nutrition 0.000 description 5
- 206010039966 Senile dementia Diseases 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010013980 Dyssomnias Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 230000001960 triggered effect Effects 0.000 description 2
- 102000004219 Brain-derived neurotrophic factor Human genes 0.000 description 1
- 108090000715 Brain-derived neurotrophic factor Proteins 0.000 description 1
- 208000018152 Cerebral disease Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 230000004611 cancer cell death Effects 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 235000021438 curry Nutrition 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000008694 endothelial dysfunction Effects 0.000 description 1
- 230000008753 endothelial function Effects 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000013410 fast food Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 210000004126 nerve fiber Anatomy 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a kind of turmeric lecithin solid beverage, belong to technical field of health care food.The technical scheme is that：A kind of turmeric lecithin solid beverage, contains soybean lecithin, turmeric.Turmeric lecithin solid beverage of the present invention, on the basis of original component function is kept, the compatibility of turmeric and lecithin generates synergy.With stronger antifatigue, anti-senescence function；Human body blood fat, blood pressure, blood glucose can also be adjusted and be in normal range (NR)；Also there is good function of tumor inhibition, be the essential food that people maintain health.
Description
【Technical field】
The present invention relates to a kind of turmeric lecithin solid beverage, belong to technical field of health care food.
【Background technology】
It is known that food should be diversified, but with the quickening of modern life rhythm, life stress and operating pressure
The problems such as, it is varied that people do not have excessive time and efforts to prepare food.Especially working clan, more with fast food generation
Replace, have no time to attend to the diversity of nutrition.And the unhealthful modern disease such as dyssomnias, insomnia and dreamful sleep occurs in some crowds；
For also some crowds due to growth in the living standard, 40 years old or so is high fat of blood, hyperglycaemia, the critical value of hypertension occur,
There is 30 years old women the situation of improper amenorrhoea occur.
Long-term dyssomnias, insomnia and dreamful sleep, substantial variation can be triggered, such as early senile dementia, or even can influence to give birth to
Life.Long-term high fat of blood, hypertension, hyperglycaemia can trigger the angiocardiopathies such as hypertension.If disease comes,
I guess it is probably late, if a kind of health food can be provided for people in daily life, mouthfeel, and can either be met
Enough solve human body sub-health state, and can enough safeguard human body blood health, reach the purpose promoted longevity, be people very
Desired thing.
【The content of the invention】
【Goal of the invention】
It is an object of the invention to provide a kind of turmeric lecithin solid beverage, can either solve the sub-health state of human body,
And can enough safeguards the blood health of human body, reaches the purpose promoted longevity
【Technical scheme】
The technical scheme is that：A kind of turmeric lecithin solid beverage, contains soybean lecithin, turmeric.
Currently preferred technical scheme：A kind of turmeric lecithin solid beverage, contain soybean lecithin 1-2 parts, turmeric
0.8-1.5 parts.
Currently preferred technical scheme：The turmeric lecithin solid beverage of unit dose, containing soybean lecithin 1-2g,
Turmeric 0.8-1.5g.
Currently preferred technical scheme：The turmeric lecithin solid beverage of unit dose, containing soybean lecithin 1.5g,
Turmeric 1.2g.
The preparation method of turmeric lecithin solid beverage of the present invention, comprises the following steps：
Step 1, soybean lecithin, turmeric cross 100 mesh sieves respectively；
Step 2, soybean lecithin, turmeric that the first step of formula ratio is sieved are weighed, mixed；
Step 3, packing.
In technical solution of the present invention, soybean lecithin is the essence substance in soybean, is described as with protein, vitamin simultaneously
" the 3rd nutrient " of row.Lecithin is the basic substance in human body cell, is responsible for the information and energy transmission of cell.Work as human body
In lecithin abundance when, it is meant that the metabolism power of human body, immunity and vitality are abundant.Can effectively adjust blood fat,
Protect liver, lifting brain activity, anti-aging.It is specific as follows：
Deferring senility：The cell membrane of human body cell is mainly to be made up of lecithin, and human body supplement lecithin can be with
The cell membrane being damaged is repaired, increases the degree of unsaturation of the aliphatic acid of cell membrane, improves the function of film, makes its softening and youth
Change, which improves the metabolic capability of human body, the power of regeneration of self-healing ability and body tissue, so as to strengthen human body entirety
The disease such as the aging of vitality, fundamentally delaying human body, the exercise not harmony triggered to human senility has suitable high level
Improvement, keep the health, youth and vigor of the mankind.
Adjust blood fat, reduce cholesterol function：The cholesterol for causing artery sclerosis is the waxy substance of fatty, if courage
The rich product of sterol too high levels will have a strong impact on blood circulation, be the main reason for causing cardiovascular and cerebrovascular diseases on arterial wall.Ovum
Phosphatide has the function that to significantly reduce cholesterol, triglycerides, low-density lipoprotein, and this emulsification for being primarily due to lecithin is made
With the transport and deposition that have impact on cholesterol and fat, and it can remove superfluous triglycerides.Therefore, soybean lecithin can have
Effect reduces too high blood fat and cholesterol, and then prevents and treats cardiovascular and cerebrovascular disease because of caused by it.
Prevent and treat diabetes function：Diabetes are a kind of endocrine metabolism diseases, and most of patients all has fat metabolism barrier
Hinder, the method for reducing blood lipid is in addition to using medicine, it is also an option that soybean lecithin.The lipid-loweringing definite principle of soybean lecithin, effect
Fruit is reliable, is free from side effects, and can also improve the function of cell, improves the metabolic capability of cell, supplies the energy needed for body
Amount.
In technical solution of the present invention, turmeric is one of maximally effective natural nutrition health products.Result of study confirms it to body
Body and brain are beneficial.It is specific as follows：
Turmeric is the spices that yellow is provided to curry.It is in existing thousands of years culinary art of India and medicinal history.Most
Recent studies on finds that this herbal medicine rhizome includes the compound of health-care effect really.These materials are called turmeric class compound, its
In it is most important with curcumin.Curcumin is the main active of turmeric, is a kind of powerful antioxidant；Curcumin is a kind of
Natural anti-inflammatory compound, it is effective as some antiphlogistics；Turmeric significantly improves human body oxidation resistance, can offset free radical
Harm, in addition, curcumin can also promote the activity of body itself antioxidase；Curcumin improves BDNF,
Curcumin can improve brain function and reduce cerebral disorders risk；Curcumin reduces heart disease risk, and curcumin can help to reverse the heart
The pathogenic process of popular name for, turmeric are to promote endothelial function to the key benefit of heart, and it is the heart to have proven to blood vessel endothelium dysfunction
The major driving factor of popular name for, blood pressure can not be adjusted with endothelium, blood coagulation is relevant with other factorses；Turmeric is known as prevention cancer and made
With cancer has many forms, and taking curcumin health products has actively impact to some of cancer types, and researcher is
The possibility that turmeric is regarded to treatment of cancer herbal medicine is explored, it influences growth of cancer cells, development and the diffusion of molecular level, research
It was found that it can promote cancer cell death；Curcumin can be used for preventing and treating Alzheimer disease, and Alzheimer disease is a kind of
Common nerve fiber degenerative disease, and be the main reason for causing senile dementia, unfortunately, this is not treated so far
The Perfected process of kind disease, therefore, prevention is particularly important, and research finds that turmeric is known as prevention Alzheimer disease effect,
Because it can pass through blood-brain barrier.
Turmeric lecithin solid beverage of the present invention, adult's daily amount are advisable for 2-3 times, every time 1 packing list
Position.
【Beneficial effect】
Turmeric lecithin solid beverage of the present invention, on the basis of original component function is kept, turmeric and lecithin
Compatibility generate synergy.With stronger antifatigue, anti-senescence function；Human body blood fat, blood pressure, blood glucose can also be adjusted
In normal range (NR)；Also there is good function of tumor inhibition, be the essential food that people maintain health.
【Embodiment and test example】
Embodiment 1, soybean lecithin 100g, turmeric 150g, the preparation method as described in technical scheme prepare 100 bags.
Embodiment 2, soybean lecithin 200g, turmeric 80g, the preparation method as described in technical scheme prepare 100 bags.
Embodiment 3, soybean lecithin 150g, turmeric 120g, the preparation method as described in technical scheme prepare 100 bags.
The improper people of amenorrhoea women 30 is collected in test example 1, outpatient service, is randomly divided into 3 groups, takes 1- of the embodiment of the present invention respectively
3 product, 2 times a day, 1 bag, continuously takes 4 months every time, and amenorrhoea symptom disappears, and menstruation recovery is normal.Illustrate present invention production
Power has good anti-senescence function.
Test example 2, outpatient service collect 60 people that blood fat, blood pressure, blood glucose are in critical value, and main suit is dizzy, weak, at random
It is divided into 3 groups, takes 1-3 of embodiment of the present invention product respectively, 2 times a day, 1 bag, continuously takes 3 months, full complement every time
Dizzy, the asymptomatic disappearance of body, patient examination blood fat, blood pressure, blood glucose are normal, and period occurs without flu.Illustrate of the invention real
Applying a product has the function that to safeguard that blood fat, blood pressure, blood glucose are in normal range (NR) very well.
The people of Tumor Patients after Chemotherapy 80 is collected in test example 3, outpatient service, is randomly divided into 4 groups, respectively embodiment 1-3 groups and control
Group.Embodiment group takes 1-3 of embodiment of the present invention product, 2 times a day, often respectively on the basis of former therapeutic scheme is continued
Secondary 1 bag；Reference examples group continues former therapeutic scheme.Embodiment 1-3 groups are continuously taken 3 months, and symptom and indices are significantly better than
Control group.Illustrate that product of the present invention has good anti-tumor function.
Claims (5)
1. a kind of turmeric lecithin solid beverage, it is characterised in that contain soybean lecithin, turmeric.
2. according to turmeric lecithin solid beverage described in claim 1, it is characterised in that contain soybean lecithin 1-2 parts, turmeric
0.8-1.5 parts.
3. according to turmeric lecithin solid beverage described in claim 1, it is characterised in that the turmeric lecithin solid of unit dose
In beverage, contain soybean lecithin 1-2g, turmeric 0.8-1.5g.
4. according to turmeric lecithin solid beverage described in claim 1, it is characterised in that the turmeric lecithin solid of unit dose
In beverage, contain soybean lecithin 1.5g, turmeric 1.2g.
5. the preparation method of turmeric lecithin solid beverage described in claim 1, it is characterised in that comprise the following steps：
Step 1 soybean lecithin, turmeric cross 100 mesh sieves respectively；
Step 2 weighs the soybean lecithin of the first step sieving of formula ratio, turmeric, mixes；
Step 3 dispenses.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711226937.0A CN107853528A (en) | 2017-11-29 | 2017-11-29 | A kind of turmeric lecithin solid beverage |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711226937.0A CN107853528A (en) | 2017-11-29 | 2017-11-29 | A kind of turmeric lecithin solid beverage |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107853528A true CN107853528A (en) | 2018-03-30 |
Family
ID=61704545
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201711226937.0A Pending CN107853528A (en) | 2017-11-29 | 2017-11-29 | A kind of turmeric lecithin solid beverage |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107853528A (en) |
-
2017
- 2017-11-29 CN CN201711226937.0A patent/CN107853528A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101882400B1 (en) | A diet injectable composition containing an improved component of cellulite and an antioxidant active ingredient, a decrease in edema and a relieving component of pain | |
| US11337945B2 (en) | C5 ketone compositions, and related methods, for therapeutic and performance supplementation | |
| CN104208654A (en) | Healthcare prescription mainly containing earthworm protein extract | |
| CN1970007A (en) | Capsule for improving sexual function for men | |
| CN103230015A (en) | Extract compound for delaying senility, improving immunity and preventing and resisting cancer | |
| CN105232907A (en) | Beverage capable of invigorating kidney and strengthening Yang and making method thereof | |
| EP2859896A1 (en) | Pharmaceutical compositions for the treatment of muscular disorders | |
| US10350257B2 (en) | Pharmaceutical composition containing complex extract of Crataegi fructus and Citri pericarpium as an active ingredient for treating or preventing obesity or lipid-related metabolic diseases | |
| CN100475254C (en) | Anti-fatigue resistibility capsules for improving body immunity and method for making same | |
| EP3135281A1 (en) | Composition for preventing or improving peripheral neuropathy | |
| CN102309004A (en) | Functional health food with lowering cholesterol | |
| KR100518179B1 (en) | Composition for improvement of sexual function | |
| CN107853528A (en) | A kind of turmeric lecithin solid beverage | |
| CN104256618B (en) | A kind of hypoglycemic food, health products or pharmaceutical composition | |
| CN102631503A (en) | Antifatigue traditional Chinese medicine composition and preparation method thereof | |
| CN112352945A (en) | Artificial cordyceps militaris food with effects of resisting fatigue and improving immunity | |
| CN105647774A (en) | Sugar apple fruit vinegar and manufacturing method thereof | |
| CN108420842A (en) | A kind of sowthistle-leaf ixeris seedling preparation of antigout effect | |
| CN107296817B (en) | Use of Poria extract and temmoic acid for protecting muscle | |
| CN100369616C (en) | Glossy ganoderma essence liquid and its usage | |
| CN102657333B (en) | Blood pressure reducing and heart protecting composite nutrient and preparation method thereof | |
| CN109954052A (en) | A kind of composition with antioxidant activity | |
| US20230414691A1 (en) | Composition including fraction of syzygium formosum extract as active ingredient | |
| RU2709488C1 (en) | Method of treating and preventing age-associated diseases | |
| CN1318062C (en) | Composition containing extracts of pagodatree fruits, grape seeds and peel and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180330 |